Diablo Clinical Research Inc is categorized under in Walnut Creek, CA and active since 1995.
Diablo Clinical Research Inc was established in 1995, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Catherine Morimoto, Director at the company’s single location by writing to 2255 Ygnacio Valley Road # M, Walnut Creek, California CA 94598 or by phoning (925) 930-7267. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Diablo Clinical Research Inc |
| Contact Person: | Catherine Morimoto, Director |
| Address: | 2255 Ygnacio Valley Road # M, Walnut Creek, California 94598 |
| Phone Number: | (925) 930-7267 |
| Website Address: | diabloclinical.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 6214930 |
| Share This Business: |
Diablo Clinical Research Inc was started in 1995 to provide professional under the SIC code 2834 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Catherine Morimoto, Director for inquiries that concern Diablo Clinical Research Inc by calling the company number (925) 930-7267, as your correspondence is most welcome. Additionally, the physical location of the single location of Diablo Clinical Research Inc can be found at the coordinates 37.92296,-122.029066 as well as the street address 2255 Ygnacio Valley Road # M in Walnut Creek, California 94598.
For its online presence, you may visit Diablo Clinical Research Inc’s website at diabloclinical.com and engage with its social media outlets through on Twitter and on Facebook.